Why the study?
What are the outcomes of contemporary family screening and genetic testing in relatives of patients with hypertrophic cardiomyopathy?
What are the outcomes of contemporary family screening and genetic testing in relatives of patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Contemporary family screening and genetic testing effectively identify HCM in at-risk relatives while allowing nearly half of the population to be safely discharged from long-term clinical follow-up.
HCM was identified in 30% of relatives at first screening, and 16% developed HCM during 7 years of repeated evaluation. GT led to a discharge from clinical follow-up in 46% of the study population. Survival in the relatives was good.
No takes yet. Share an insight, caveat, or question.
Velzen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: